Document Detail


Aerosolized prostacyclins.
MedLine Citation:
PMID:  15165299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two prostacyclins (prostaglandin E(1) and prostaglandin I(2)) are potent vasodilators. Aerosolized prostacyclins reduce pulmonary artery pressure, improve right heart function, and increase arterial oxygenation by improving ventilation/perfusion matching. This report describes aerosolized prostacyclins and compares them to inhaled nitric oxide. I review the types of inhalable prostacyclins and their indications, evidence of efficacy, delivery, and adverse effects.
Authors:
Mark Siobal
Related Documents :
1282969 - Endothelium-dependent and -independent vasodilation and reactive hyperemia in healthy s...
20025149 - Effects of acute nitric oxide synthase inhibition on lower leg vascular function in chr...
11922959 - Responses of isolated perfused uterine vascular beds of nonpregnant and pregnant rats t...
8357359 - Inhaled nitric oxide for the adult respiratory distress syndrome.
18927469 - Interaction between p450 eicosanoids and nitric oxide in the control of arterial tone i...
15126249 - Response of descending vasa recta to luminal pressure.
18195169 - Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic...
3933979 - Brain metabolism in deep controlled hypotension in neurosurgical patients.
24937379 - Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced...
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Respiratory care     Volume:  49     ISSN:  0020-1324     ISO Abbreviation:  Respir Care     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-05-28     Completed Date:  2004-09-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7510357     Medline TA:  Respir Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  640-52     Citation Subset:  IM    
Affiliation:
Respiratory Care Services, San Francisco General Hospital, NH GA-2, 1001 Potrero Avenue, San Francisco, CA 94110, USA. msiobal@sfghsom.ucsf.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Aerosols
Alprostadil / administration & dosage
Dose-Response Relationship, Drug
Epoprostenol / administration & dosage
Equipment Design
Humans
Hypertension, Pulmonary / drug therapy
Iloprost / administration & dosage
Nebulizers and Vaporizers
Nitric Oxide / administration & dosage
Prostaglandins I / administration & dosage*,  adverse effects
Respiratory Distress Syndrome, Adult / drug therapy
Respiratory Therapy / instrumentation,  methods*
Treatment Outcome
Vasodilator Agents / administration & dosage*,  adverse effects
Ventricular Dysfunction, Right / drug therapy
Chemical
Reg. No./Substance:
0/Aerosols; 0/Prostaglandins I; 0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 35121-78-9/Epoprostenol; 745-65-3/Alprostadil; 78919-13-8/Iloprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aerosolized antibiotics in mechanically ventilated patients.
Next Document:  Aerosol delivery to ventilated infant and pediatric patients.